Liver Cirrhosis, Alcoholic clinical trials
The registry lists 45 studies for Liver Cirrhosis, Alcoholic across more than 10 countries. 14 are recruiting or about to start. 28 of them are mainly about Liver Cirrhosis, Alcoholic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.
Get an email when these change. Save the Liver Cirrhosis, Alcoholic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Pharmicell Co., Ltd. (5) · Assistance Publique - Hôpitaux de Paris (4) · Copenhagen University Hospital, Hvidovre (2) · University of Louisville (2) · University Hospital, Lille (2) · Odense University Hospital (2) · Stempeutics Research Pvt Ltd (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)
What is being tested here
Drugs under test in Liver Cirrhosis, Alcoholic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 4
- Dec 2026Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LC · Pharmicell Co., Ltd.
- Mar 2027SAMe Trial for Patients With Alcoholic Cirrhosis · Indiana University
- Apr 2027Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease · University Hospital, Lille
- Apr 2027Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement · Stephanie Gräger
Who these studies take
Of the 8 Liver Cirrhosis, Alcoholic studies recruiting now, 2 (25%) set no upper age limit and 5 (63%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (13%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 6 (75%) | 6 (75%) |
| 30 | 8 (100%) | 8 (100%) |
| 40 | 8 (100%) | 8 (100%) |
| 50 | 8 (100%) | 8 (100%) |
| 65 | 8 (100%) | 8 (100%) |
| 75 | 5 (63%) | 5 (63%) |
| 85 | 3 (38%) | 3 (38%) |
Across all 45 studies, recruiting or not: 51% stop at 75 or younger and 11% at 65; 4% take children; 0% are for women only and 0% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 15, 2026.
Newly registered2
Studies
Recruiting first, then most recently updated. Showing 45 of 45. search them.
- Study to Evaluate ALN-CIDEB in Adults With Fibrotic Alcohol-Associated Liver Disease (ALD)Not yet recruitingNCT07933328Phase 2
- Inflammatory and Neuroimmune Guided Investigation of Underlying Fatigue in Patients With CirrhosisNot yet recruitingNCT07899736
- Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesRecruitingNCT05832229Phase 21 country
- Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LCRecruitingNCT050938811 country
- Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic CirrhosisRecruitingNCT04689152Phase 31 country
- A-TANGO Phase 2 StudyRecruitingNCT06890039Phase 21 country
- Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) PlacementRecruitingNCT06814990Not applicable1 country
- Pomegranate Dietary Supplements in AUD and ALDNot yet recruitingNCT076785671 country
- Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver DiseaseRecruitingNCT041065181 country
- SAMe Trial for Patients With Alcoholic CirrhosisRecruitingNCT04250259Phase 21 country
- Financial Rewards for Reducing Alcohol Use in Patients With Liver DiseaseNot yet recruitingNCT07465588Not applicable
- Optimized Remission in Alcohol-related Liver CirrhosisRecruitingNCT06866496Not applicable1 country
- Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol ConsumptionEnrolling by invitationNCT068406521 country
- Feasibility of Wearable Biosensors for Monitoring Daily Activity, Heart Rate, and Sleep Among Patients With Decompensated CirrhosisNot yet recruitingNCT06057870
- Is Access to Liver Transplantation Similar in Alcoholic or Not Patients?CompletedNCT018208191 country
- Liver Cirrhosis Network Cohort StudyActive, not recruitingNCT057403581 country
- Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical TreatmentCompletedNCT01756794Not applicable2 countries
- Mild Hypothermia and Acute Kidney Injury in Liver TransplantationTerminatedNCT03534141Not applicable1 country
- Study of Prevalence of Eating Disorder in Liver Transplant PatientsCompletedNCT060939191 country
- Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic MicrobiotaActive, not recruitingNCT03863730Not applicable1 country
- Study of Decompensated Alcoholic Cirrhosis Treatment by Stem CellsStatus unknownNCT05155657Phase 11 country
- Early Detection of Alcoholic Liver DiseaseWithdrawnNCT04070508
- Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic CirrhosisTerminatedNCT035083881 country
- SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic EncephalopathyTerminatedNCT02811887Not applicable1 country
- Pegfilgrastim in Patients With Alcoholic HepatitisCompletedNCT02776059Phase 21 country
- Pangenomic Study During Alcoholic CirrhosisCompletedNCT010652331 country
- Zinc Supplementation in Alcoholic CirrhosisCompletedNCT02072746Not applicable1 country
- EUS Based Prevalence of Chronic Pancreatitis in Alcoholic CirrhosisStatus unknownNCT042451891 country
- Long-term Follow-up Study of Livercellgram in Alcoholic LC Patients Who Completed Livercellgram Phase 2 StudyCompletedNCT028060111 country
- Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LCStatus unknownNCT03838250Phase 11 country
- Prospective Cohort Study of Disease and Outcomes in CirrhosisStatus unknownNCT044222231 country
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore AreaCompletedNCT009137571 country
- Alcohol Biomarker StudyStatus unknownNCT043634241 country
- National Cohort of Uncomplicated Alcoholic CirrhosisStatus unknownNCT012139271 country
- Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With HepatocarcinomaCompletedNCT008277231 country
- Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic PatientsTerminatedNCT00188045Phase 4
- Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic HepatitisCompletedNCT02326103Early Phase 11 country
- Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic UltrasoundCompletedNCT012083111 country
- Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver CirrhosisCompletedNCT01591200Phase 21 country
- REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)CompletedNCT01875081Phase 21 country
- Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic CirrhosisTerminatedNCT01342705Phase 31 country
- Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in HumanCompletedNCT00388323Not applicable1 country
- The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver CirrhosisStatus unknownNCT01741090Phase 21 country
- Efficacy of Baclofen in the Treatment of Alcohol AddictionCompletedNCT00525252Phase 1/2
- Prevention of Decompensation in Liver CirrhosisStatus unknownNCT00239096Phase 41 country